FDA: EUAs for COVID-19 Lab Tests Will Continue after PHE Ends
Agency says it will continue to have authority to clear new lab tests and other COVID-19 products on an emergency basis even after the PHE ends.
FDA-nir
Subscribe today for access to
Articles and Reports
Empowered Dx in Hot Water with FDA Again Over COVID-19 Test Kits
At the end of 2022, the agency sent a new warning letter to Empowered for unauthorized distribution of COVID-19 test kits.
FDA Tightens the Screws on EUA Review of COVID-19 Tests
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
LDT Regulation Appears to Be Stalled
...
Already a member? Log in here
23andMe Ordered to Stop Marketing Genome Service
...
Already a member? Log in here
Justice Department Sets Record in Fraud Recoveries
...
Already a member? Log in here
Senator Questions ‘Conflicting’ HHS Policies On Patient Access to Lab Data
...
Already a member? Log in here
CMS Proposes Hepatitis C Screening for Eligible Adults
...
Already a member? Log in here
FDA Updates 2008 Guidance on Categories of Lab Testing
...
Already a member? Log in here
AMP Expresses Concerns About Product Labeling in Letter to FDA
...
Already a member? Log in here
Stakeholder Group Calls for Reform of CLIA Waiver Process
...
Already a member? Log in here